-
1دورية أكاديميةOphthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin
المؤلفون: Novelli, Fernando José de, Przysiezny, André, Rosa, Evandro Luis, Garcia, Raquel Francine Liermann, Nóbrega, Mário Junqueira
المصدر: Arquivos Brasileiros de Oftalmologia. June 2014 77(3)
مصطلحات موضوعية: Antiviral agents/adverse effects, Hepatitis C, chronic/drug therapy, Interferon-alpha/adverse effects, Retinal diseases/chemically induced, Ribavirin/ adverse effects
وصف الملف: text/html
-
2
المؤلفون: GUARD C, Study Group, Hassanein, T, Bakalos, G, Ahlers, S, Shiffman, Ml, Tallarico, L, Reddy, Kr, Orlandini, A, Ferenci, P, Derbala, M, Coppola, C, Foster, Gr, Basho, J, Shabanaj, G, Harxhi, A, Debzi, N, Afredj, N, Guessab, N, Mahindad, N, Mahiou, H, Aissaoui, M, Al Qameesh, J, Al Ghandoor, Z, Assene, C, Bastens, B, Brixko, C, Cool, M, De Galocsy, C, Delwaide, J, George, C, Laukens, P, Lefebvre, V, Mulkay, Jp, Nevens, F, Servais, B, Van Vlierberghe, H, Horsmans, Y, Henrion, J, Sprengers, D, Michielsen, P, Bourgeois, S, Lasser, L, Langlet, P, Robaeys, G, Martinet, Jp, Warzee, P, Hoste, P, Reynaert, H, Juriens, I, Decaestecker, J, Van Der Meersch, F, Janssens, F, Ahmetagic, S, Verhaz, A, Bevanda, M, Calkic, L, Ibrahimpasic, N, Mesihovic, R, Mello, Ce, Ruiz, Fj, Martins Junior, E, Ferraz, Ml, Silva, G, Mendes, C, Lyra, A, Silva, Mh, Gomide, G, Fernandes, Jc, Pereira, P, Correa, Mc, Teixeira, R, Yousry, A, Hanno, A, Gabr, M, Omar, A, Esmat, G, Karatapanis, S, Nikolopoulou, V, Giannoulis, G, Manolakopoulos, S, Elefsiniotis, I, Drakoulis, C, Dimitroulopoulos, D, Kanatakis, S, Ketikoglou, I, Mimidis, K, Evgenidis, N, Akriviades, E, Vafiadi Zoubouli, I, Tsianos, E, Mela, M, Orfanou, E, Mousoulis, G, Karagiannis, I, Manesis, E, Varga, M, Nemesánszky, E, Fried, K, Schuller, J, Szalay, F, Lengyel, G, Tornai, I, Banyai, T, Lesch, M, Nagy, I, Gervain, J, Tusnadi, A, Schneider, F, Szentgyörgyi, L, Hunyady, B, Vincze, A, Tolvaj, G, Varkonyi, I, Makkai, E, Enyedi, J, Racz, I, Hausinger, P, Váczi, Z, Patai, Á, Ozsvár, Z, Lakner, L, Ribiczey, P, Bhalla, A, Somani, S, Luaia, R, Rao, P, Philip, M, Lawate, P, Nagral, A, Sood, A, Parikh, S, Merat, S, Nassiri Toosi, M, Alavian, Sm, Zali, Mr, Daryani, Ne, Drenaggi, D, Attili, Af, Bandiera, F, Bassi, P, Bellati, G, Bellantani, S, Brunetto, MAURIZIA ROSSANA, Bruno, S, Castelli, F, Castellacci, R, Cattelan, Am, Colombo, M, Craxi, A, D'Angelo, S, Colombo, S, Demelia, L, Di Perri, G, Di Giacomo, A, Ferrari, C, Francisci, D, Casinelli, K, Ganga, R, Costa, C, Mangia, A, Russo, Fp, Matarazzo, F, Mazzella, G, Mazzeo, M, Memoli, M, Montalbano, M, Montalto, G, Pieri, A, Passariello, N, Picciotto, A, Pietrangelo, A, Pirisi, M, Quirino, T, Raimondo, G, Rapaccini, Gl, Rizzardini, G, Rizzetto, M, Russello, M, Sabusco, G, Santantonio, T, Soardo, G, Amedea, A, Verucchi, G, Vinelli, F, Zignego, Al, Zuin, M, Ascione, A, Vinci, M, Pigozzi, Mg, Tundo, P, Saracco, Gm, Amoroso, P, Andreoni, M, Colletta, C, Erne, E, Megna, As, Biglino, A, Chiriaco, P, Foti, G, Spinzi, G, D'Amico, E, Paik, Sw, Ahn, Sh, Lee, Yn, Kim, Y, Yang, J, Han, Sy, Varghese, R, Al Gharabally, A, Askar, H, Sharara, A, Yaghi, C, Rached, Aa, Houmani, Z, Zaarour, F, Dohaibi, A, Ivanovski, L, Joksimovic, N, Abbas, Z, Memon, S, Mohsin, A, Masood, S, Hashmi, Z, Halota, W, Deron, Z, Mazur, W, Flisiak, R, Lipczynski, A, Musialik, J, Piekarska, A, Augustyniak, K, Baka Cwierz, B, Simon, K, Gietka, A, Berak, H, Sieklucki, J, Radowska, D, Szlauer, B, Piekos, T, Olszok, I, Jablkowski, M, Orszulak, G, Warakomska, I, Aleixo, Mj, Valente, C, Macedo, G, Sarmento Castro, R, Roxo, F, Faria, T, Mansinho, K, Velez, J, Ramos, Jp, Guerreiro, H, Alberto, S, Monteverde, C, Serejo, F, Peixe, P, Malhado, J, Curescu, M, Streinu Cercel, A, Caruntu, F, Livia, H, Preotescu, L, Arama, V, Ancuta, I, Gheorghe, L, Stanciu, C, Trifan, A, Acalovschi, M, Andreica, V, Pascu, O, Lencu, M, Sporea, I, Olteanu, D, Ionita Radu, F, Fierbinteanu Braticevici, C, Motoc, A, Silaghi, R, Musat, M, Coman, F, Stan, M, Cijevschi, C, Miftode, E, Delic, D, Jesic, R, Nozic, D, Svorcan, P, Fabri, M, Konstantinovic, L, Pelemis, M, Jankovic, G, Todorovic, Z, Nagorni, A, Kupcova, V, Skladany, L, Szantova, M, Krkoska, D, Jarcuska, P, Schreter, I, Oltman, M, Bocakova, J, Bunganic, I, Holoman, J, Giguere, A, Abdou, A. M.
المساهمون: Basic (bio-) Medical Sciences, Gastroenterology, Laboratory of Molecullar and Cellular Therapy, Liver Cell Biology, Michielsen, Peter, GUARD-C Study Group, Graham R. Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K. Rajender Reddy, Ludovico Tallarico, Mitchell L. Shiffman, Silke Ahler, Georgios Bakalo, Tarek Hassanein, GUARD-C Study Group: [.., Davide Drenaggi, Adolfo Francesco Attili, Franco Bandiera, Paolo Bassi, Giorgio Bellati, Stefano Bellantani, Maurizia Brunetto, Savino Bruno, Francesco Castelli, Roberto Castellacci, Anna Maria Cattelan, Massimo Colombo, Antonio Craxi, Salvatore D'angelo, Silvia Colombo, Luigi Demelia, Giovanni Di Perri, Antonio Di Giacomo, Carlo Ferrari, Daniela Francisci, Katia Casinelli, Roberto Ganga, Chiara Costa, Alessandra Mangia, Francesco Paolo Russo, Filippo Matarazzo, Giuseppe Mazzella, Maurizio Mazzeo, Massimo Memoli, Marzia Montalbano, Giuseppe Montalto, Alessandro Pieri, Nicola Passariello, Antonio Picciotto, Antonello Pietrangelo, Mario Pirisi, Tiziana Quirino, Giovanni Raimondo, Gian Ludovico Rapaccini, Giuliano Rizzardini, Mario Rizzetto, Maurizio Russello, Giuseppe Sabusco, Teresa Santantonio, Giorgio Soardo, Alessandri Amedea, Gabriella Verucchi, Francesco Vinelli, Anna Linda Zignego, Massimo Zuin, Antonio Ascione, Maria Vinci, Maria Graziella Pigozzi, Paolo Tundo, Giorgio Maria Saracco, Pietro Amoroso, Massimo Andreoni, Cosimo Colletta, Elke Erne, Angelo Salomone Megna, Alberto Biglino, Piergiorgio Chiriaco, Giuseppe Foti, Giancarlo Spinzi, Emilio D'amico, …], Foster G.R., Coppola C., Derbala M., Ferenci P., Orlandini A., Reddy K.R., Tallarico L., Shiffman M.L., Ahlers S., Bakalos G., Hassanein T., Basho J., Shabanaj G., Harxhi A., Debzi N., Afredj N., Guessab N., Mahindad N., Mahiou H., Aissaoui M., Al Qameesh J., Al Ghandoor Z., Assene C., Bastens B., Brixko C., Cool M., De Galocsy C., Delwaide J., George C., Laukens P., Lefebvre V., Mulkay J.-P., Nevens F., Servais B., Van Vlierberghe H., Horsmans Y., Henrion J., Sprengers D., Michielsen P., Bourgeois S., Lasser L., Langlet P., Robaeys G., Martinet J.-P., Warzee P., Hoste P., Reynaert H., Juriens I., Decaestecker J., Van Der Meersch F., Janssens F., Ahmetagic S., Verhaz A., Bevanda M., Calkic L., Ibrahimpasic N., Mesihovic R., Mello C.E., Ruiz F.J., Junior E.M., Ferraz M.L., Silva G., Mendes C., Lyra A., Silva M.H., Gomide G., Fernandes J.C., Pereira P., Correa M.C., Teixeira R., Yousry A., Hanno A., Gabr M., Omar A., Esmat G., Karatapanis S., Nikolopoulou V., Giannoulis G., Manolakopoulos S., Elefsiniotis I., Drakoulis C., Dimitroulopoulos D., Kanatakis S., Ketikoglou I., Mimidis K., Evgenidis N., Akriviades E., Vafiadi-Zoubouli I., Tsianos E., Mela M., Orfanou E., Mousoulis G., Karagiannis I., Manesis E., Varga M., Nemesanszky E., Fried K., Schuller J., Szalay F., Lengyel G., Tornai I., Banyai T., Lesch M., Nagy I., Gervain J., Tusnadi A., Schneider F., Szentgyorgyi L., Hunyady B., Vincze A., Tolvaj G., Varkonyi I., Makkai E., Enyedi J., Racz I., Hausinger P., Vaczi Z., Patai A., Ozsvar Z., Lakner L., Ribiczey P., Bhalla A., Somani S., Luaia R., Rao P., Philip M., Lawate P., Nagral A., Sood A., Parikh S., Merat S., Nassiri-Toosi M., Alavian S.-M., Zali M.R., Daryani N.E., Drenaggi D., Attili A.F., Bandiera F., Bassi P., Bellati G., Bellantani S., Brunetto M., Bruno S., Castelli F., Castellacci R., Cattelan A.M., Colombo M., Craxi A., D'angelo S., Colombo S., Demelia L., Di Perri G., Di Giacomo A., Ferrari C., Francisci D., Casinelli K., Ganga R., Costa C., Mangia A., Russo F.P., Matarazzo F., Mazzella G., Mazzeo M., Memoli M., Montalbano M., Montalto G., Pieri A., Passariello N., Picciotto A., Pietrangelo A., Pirisi M., Quirino T., Raimondo G., Rapaccini G.L., Rizzardini G., Rizzetto M., Russello M., Sabusco G., Santantonio T., Soardo G., Amedea A., Verucchi G., Vinelli F., Zignego A.L., Zuin M., Ascione A., Vinci M., Pigozzi M.G., Tundo P., Saracco G.M., Amoroso P., Andreoni M., Colletta C., Erne E., Megna A.S., Biglino A., Chiriaco P., Foti G., Spinzi G., D'amico E., Paik S.W., Ahn S.-H., Lee Y.N., Kim Y., Yang J., Han S.Y., Varghese R., Al Gharabally A., Askar H., Sharara A., Yaghi C., Abou Rached A., Houmani Z., Zaarour F., Dohaibi A., Ivanovski L., Joksimovic N., Abbas Z., Memon S., Mohsin A., Masood S., Hashmi Z., Halota W., Deron Z., Mazur W., Flisiak R., Lipczynski A., Musialik J., Piekarska A., Augustyniak K., Baka-Cwierz B., Simon K., Gietka A., Berak H., Sieklucki J., Radowska D., Szlauer B., Piekos T., Olszok I., Jablkowski M., Orszulak G., Warakomska I., Aleixo M.J., Valente C., Macedo G., Sarmento-Castro R., Roxo F., Faria T., Mansinho K., Velez J., Ramos J.P., Guerreiro H., Alberto S., Monteverde C., Serejo F., Peixe P., Malhado J., Curescu M., Streinu-Cercel A., Caruntu F., Livia H., Preotescu L., Arama V., Ancuta I., Gheorghe L., Stanciu C., Trifan A., Acalovschi M., Andreica V., Pascu O., Lencu M., Sporea I., Olteanu D., Ionita-Radu F., Fierbinteanu-Braticevici C., Motoc A., Silaghi R., Musat M., Coman F., Stan M., Cijevschi C., Miftode E., Delic D., Jesic R., Nozic D., Svorcan P., Fabri M., Konstantinovic L., Pelemis M., Jankovic G., Todorovic Z., Nagorni A., Kupcova V., Skladany L., Szantova M., Krkoska D., Jarcuska P., Schreter I., Oltman M., Bocakova J., Bunganic I., Holoman J., Giguere A., Abdou A.M.S., UCL - SSS/IREC-Institut de recherche expérimentale et clinique, UCL - SSS/IREC/GAEN-Pôle d'Hépato-gastro-entérologie, UCL - (SLuc) Service de gastro-entérologie
المصدر: PLoS ONE
PLOS ONE
PLoS ONE, Vol 11, Iss 3, p e0151703 (2016)
PLoS One, Vol. 11, no. 3, p. e0151703 [1-20] (2016)مصطلحات موضوعية: Genetics and Molecular Biology (all), Male, Chronic Hepatitis, Hepacivirus, Ribavirin/adverse effects, Asthenia/chemically induced, Polyethylene Glycol, Biochemistry, Polyethylene Glycols, Body Mass Index, Chronic Liver Disease, 0302 clinical medicine, Neutropenia/chemically induced, Interferon-alpha/adverse effects, Medicine, Chronic, lcsh:Science, Liver Diseases, virus diseases, Antiviral Agents/adverse effects, Cohort, Science & Technology - Other Topics, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Cohort study, Human, medicine.medical_specialty, Alpha interferon, Gastroenterology and Hepatology, Antiviral Agents, Microbiology, Dose-Response Relationship, 03 medical and health sciences, Pharmacotherapy, Hepatitis C, Chronic/drug therapy, Dose Prediction Methods, Drug Therapy, Anemia/chemically induced, Humans, Hemoglobin, Aged, Medicine and health sciences, Biochemistry, Genetics and Molecular Biology (all), Hepaciviru, Science & Technology, Dose-Response Relationship, Drug, Flaviviruses, lcsh:R, Organisms, Biology and Life Sciences, Proteins, medicine.disease, digestive system diseases, chemistry, Agricultural and Biological Sciences (all), Withholding Treatment, Asthenia, Immunology, Proportional Hazards Model, lcsh:Q, Human medicine, RNA viruses, Physiology, lcsh:Medicine, Peginterferon-alfa, Polyethylene Glycols/adverse effects, Adult, Anemia, Cohort Studies, Female, Hepatitis C, Chronic, Host-Pathogen Interactions, Interferon-alpha, Middle Aged, Neutropenia, Outcome Assessment (Health Care), Proportional Hazards Models, RNA, Viral, Recombinant Proteins, Ribavirin, Medicine (all), chemistry.chemical_compound, Outcome Assessment, Health Care, Medicine and Health Sciences, 030212 general & internal medicine, Viral, Pathology and laboratory medicine, Multidisciplinary, biology, Hepatitis C virus, Pharmaceutics, Hepatitis C, Hematology, Recombinant Protein, Outcome Assessment (Health Care)/methods, Medical microbiology, Host-Pathogen Interaction, Multidisciplinary Sciences, Physiological Parameters, Research Design, Combination, Viruses, Drug, Pathogens, Host-Pathogen Interactions/drug effects, Research Article, Clinical Research Design, Research and Analysis Methods, Internal medicine, Recombinant Proteins/adverse effects, RNA, Viral/blood, Antiviral Agent, business.industry, Body Weight, Hepacivirus/drug effects, Viral pathogens, biology.organism_classification, Hepatitis viruses, Microbial pathogens, RNA, Adverse Events, Cohort Studie, business
وصف الملف: Electronic-eCollection; application/pdf; pdf; STAMPA
-
3
المؤلفون: Denis Ouzan, Shuhei Nishiguchi, Anne-Marie Quinson, George Kukolj, Jerry O. Stern, Christophe Moreno, Joseph Scherer, M. V. Maevskaya, L. Morano, Filipe Calinas, Peter Ferenci, Masao Omata, Kosh Agarwal, Graham R. Foster, Yakov Datsenko, Jean-François Dufour, Marc Bourlière, Elmar Zehnter, Stefan Zeuzem, Javier Crespo, Miguel Garcia, Daniel M. Forton, Tarik Asselah, Marcus Schuchmann, Christoph Sarrazin
المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024 <http://dx.doi.org/10.1016/j.jhep.2014.12.024>مصطلحات موضوعية: Male, Aminoisobutyric Acids, Recombinant Proteins/administration & dosage, Ribavirin/adverse effects, Hepacivirus, Polyethylene Glycols/adverse effects, Pharmacology, medicine.disease_cause, Gastroenterology, Polyethylene Glycols, chemistry.chemical_compound, Pegylated interferon, Thiazoles/administration & dosage, Interferon-alpha/adverse effects, virus diseases, Middle Aged, Antiviral Agents/adverse effects, Recombinant Proteins, Tolerability, Quinolines, RNA, Viral, Drug Therapy, Combination, Female, Oligopeptides, Antiviral Agents/administration & dosage, Hepacivirus/classification, medicine.drug, Adult, medicine.medical_specialty, Proline, Genotype, Hepatitis C virus, Interferon-alpha/administration & dosage, Alpha interferon, Hepacivirus/genetics, 610 Medicine & health, Placebo, Antiviral Agents, Oligopeptides/administration & dosage, Hepatitis C, Chronic/drug therapy, Double-Blind Method, Leucine, Internal medicine, Hepatitis C, Chronic/virology, Ribavirin, medicine, Recombinant Proteins/adverse effects, Humans, RNA, Viral/blood, Polyethylene Glycols/administration & dosage, Intention-to-treat analysis, Hepatology, business.industry, Hepacivirus/drug effects, Interferon-alpha, Hepatitis C, Chronic, CHLC GAS, Thiazoles, Thiazoles/adverse effects, chemistry, Faldaprevir, business, Ribavirin/administration & dosage, Oligopeptides/adverse effects
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48feb1ddd3b1a0089ca2b28b5256ec41
-
4
المؤلفون: François Dufour, Nicolas Troilliet, Markus H. Heim, Beat Müllhaupt, Martine Monnat, Carl Oneta, Enos Bernasconi, Matthias Cavassini, Daniel Genné, Valérie Dutoit, Francesco Negro, Jan Borovicka, Jean-Philippe Chave, J. J. Gonvers, Christian Chuard, Andreas Cerny, Raffaelle Malinverni
المصدر: Schweizerische medizinische Wochenschrift, Vol. 140 (2010) P. w13055
Swiss Medical Weekly, vol. 140, pp. w13055مصطلحات موضوعية: Male, Human immunodeficiency virus (HIV), HIV Infections, Hepacivirus, medicine.disease_cause, Gastroenterology, Polyethylene Glycols, chemistry.chemical_compound, Liver disease, Antiretroviral Therapy, Highly Active, Clinical endpoint, ddc:616, Polyethylene Glycols/adverse effects/*therapeutic use, virus diseases, General Medicine, Hepatitis C, Middle Aged, Viral Load, Recombinant Proteins, Treatment Outcome, AIDS-Related Opportunistic Infections/*drug therapy, RNA, Viral, Drug Therapy, Combination, Female, HIV Infections/*drug therapy/virology, Adult, medicine.medical_specialty, Genotype, Interferon alpha-2, Interferon-alpha/adverse effects/*therapeutic use, Antiviral Agents, Drug Administration Schedule, Hepacivirus/*drug effects/genetics, Internal medicine, Ribavirin, medicine, Humans, RNA, Viral/blood, Ribavirin/adverse effects/*therapeutic use, AIDS-Related Opportunistic Infections, business.industry, Interferon-alpha, Antiviral Agents/adverse effects/*therapeutic use, Hepatitis C, Chronic, medicine.disease, Virology, Long-Term Care, digestive system diseases, Institutional repository, chemistry, AIDS-Related Opportunistic Infections/drug therapy, Antiviral Agents/adverse effects, Antiviral Agents/therapeutic use, HIV Infections/drug therapy, HIV Infections/virology, Hepacivirus/drug effects, Hepacivirus/genetics, Hepatitis C, Chronic/drug therapy, Hepatitis C, Chronic/virology, Interferon Alfa-2a/adverse effects, Interferon Alfa-2a/therapeutic use, Polyethylene Glycols/adverse effects, Polyethylene Glycols/therapeutic use, Ribavirin/adverse effects, Ribavirin/therapeutic use, Hiv patients, Comparison study, Hepatitis C, Chronic/*drug therapy/virology, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7d79afa729c95d146e89dbeda0f48c
https://pubmed.ncbi.nlm.nih.gov/20648398 -
5
المؤلفون: Evandro Luis Rosa, Fernando José De Novelli, André Przysiezny, Mário Junqueira Nóbrega, Raquel Francine Liermann Garcia
المصدر: Arquivos Brasileiros de Oftalmologia, Vol 77, Iss 3, Pp 178-181
Arquivos Brasileiros de Oftalmologia, Vol 77, Iss 3, Pp 178-181 (2014)
Arquivos Brasileiros de Oftalmologia, Volume: 77, Issue: 3, Pages: 178-181, Published: JUN 2014
Arquivos Brasileiros de Oftalmologia v.77 n.3 2014
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBOمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Time Factors, Fundus Oculi, Antiviral agents/adverse effects, Visual Acuity, Pegylated interferon α, Ribavirina/efeitos adversos, Interferon alpha-2, Antiviral Agents, Polyethylene Glycols, Ribavirin/ adverse effects, Young Adult, chemistry.chemical_compound, Retinal diseases/chemically induced, Doenças retinianas/quimicamente induzido, Retinal Diseases, lcsh:Ophthalmology, Risk Factors, Ribavirin, Interferon-alpha/adverse effects, medicine, Humans, Prospective Studies, Fluorescein Angiography, Gynecology, Agentes antivirais/efeitos adversos, business.industry, Interferon-alpha, General Medicine, Hepatitis C, Hepatitis C, Chronic, Middle Aged, Hepatite C crônica/quimioterapia, medicine.disease, Recombinant Proteins, Ophthalmology, Treatment Outcome, chemistry, lcsh:RE1-994, Interferon-alfa/efeitos adversos, Female, Visual Fields, business, Hepatitis C, chronic/drug therapy
وصف الملف: text/html
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f85d4dabd2b4a2ef4f0a32efe4b6b2
https://doi.org/10.5935/0004-2749.20140045 -
6
المؤلفون: Francesco Negro
المصدر: Best Practice & Research: Clinical Gastroenterology, Vol. 24, No 2 (2010) pp. 183-192
مصطلحات موضوعية: Cirrhosis, Hepatitis C virus, Ribavirin/adverse effects, medicine.disease_cause, Antiviral Agents, Risk Assessment, Hepatitis C, Chronic/*drug therapy, Hepatitis B, Chronic, Risk Factors, Ribavirin, medicine, Interferon-alpha/adverse effects, Humans, Adverse effect, Hepatitis B virus, ddc:616, business.industry, Gastroenterology, Interferon-alpha, Hepatitis C, Drugs, Investigational, Hepatitis B, Hepatitis C, Chronic, medicine.disease, digestive system diseases, Hepatitis B, Chronic/*drug therapy, Hepatocellular carcinoma, Antiviral Agents/*adverse effects, Immunology, Drugs, Investigational/*adverse effects, Viral hepatitis, business
-
7Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin
المؤلفون: Corrado Risino, Ignazio Di Fazio, Liborio Rampello, Mariano Malaguarnera, Aldo E. Calogero, Giovanni Pennisi, Salvatore Ranno, Lisa Cammalleri, Maria Pia Gargante, Enzo Vicari
المصدر: Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 28(10)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Ribavirin/adverse effects, Immunology, Alpha (ethology), Alpha interferon, Gastroenterology, Antiviral Agents, Basal (phylogenetics), chemistry.chemical_compound, Erectile Dysfunction/chemically induced, Drug Therapy, Erectile Dysfunction, Virology, Internal medicine, Surveys and Questionnaires, Ribavirin, medicine, Humans, Longitudinal Studies, Prospective Studies, Prospective cohort study, business.industry, Drug Therapy, Combination, Interferon-alpha, Cell Biology, Hepatitis C, Chronic, Middle Aged, medicine.disease, Sexual dysfunction, Erectile dysfunction, Cytokine, chemistry, Combination, medicine.symptom, business
-
8
المؤلفون: Spyridon Filis, Helen Vienna, Epameinondas V. Tsianos, Michael Economou, Dimitrios K. Christodoulou, Leonidas Christou
المصدر: Liver international : official journal of the International Association for the Study of the Liver. 27(3)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Population, Interferon alpha-2, Antiviral Agents, Polyethylene Glycols, chemistry.chemical_compound, Chronic hepatitis, Interferon-alpha/adverse effects/therapeutic use, Internal medicine, Ribavirin, Medicine, Humans, In patient, education, education.field_of_study, Hepatology, business.industry, virus diseases, Interferon-alpha, Antiviral Agents/adverse effects/*therapeutic use, Retrospective cohort study, Odds ratio, Hepatitis C, Chronic, Middle Aged, digestive system diseases, Recombinant Proteins, Surgery, Clinical Practice, Polyethylene Glycols/adverse effects/therapeutic use, Ribavirin/adverse effects/therapeutic use, chemistry, Retreatment, Hepatitis C, Chronic/*drug therapy/virology, Female, business, Adjuvant
-
9
المؤلفون: August-Jörg, B.S., Borovicka, J., Dufour, J.F., Gonvers, J.J., Henz, S., Hermann, R., Meyenberger, C., Weitz, M., Renner, E.L.
المساهمون: Swiss Association for the Study of the Liver
المصدر: Swiss medical weekly, vol. 133, no. 33-34, pp. 455-460
مصطلحات موضوعية: Adult, Male, Time Factors, Interferon-alpha, Pilot Projects, General Medicine, Hepatitis C, Chronic, Interferon alpha-2, Middle Aged, Aged, Antiviral Agents/administration & dosage, Antiviral Agents/adverse effects, Drug Administration Schedule, Drug Therapy, Combination, Female, Hepatitis C, Chronic/drug therapy, Humans, Interferon-alpha/administration & dosage, Interferon-alpha/adverse effects, Prospective Studies, Recombinant Proteins, Recurrence, Retreatment/adverse effects, Retreatment/methods, Ribavirin/administration & dosage, Ribavirin/adverse effects, Treatment Outcome, Antiviral Agents, Retreatment, Ribavirin
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15386a1358d694647b172136bf6aa53
https://doi.org/10.4414/smw.2003.10300 -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.